Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin
Authors: Weerawat Manosuthi
Somnuek Sungkanuparph
Ammarin Thakkinstian
Sasivimol Rattanasiri
Achara Chaovavanich
Wisit Prasithsirikul
Sirirat Likanonsakul
Kiat Ruxrungtham
Thailand Ministry of Public Health
Mahidol University
The HIV Netherlands Australia Thailand Research Collaboration
Bamrasnaradura Infectious Disease Institute
Keywords: Immunology and Microbiology
Issue Date: 15-Jul-2006
Citation: Clinical Infectious Diseases. Vol.43, No.2 (2006), 253-255
Abstract: Seventy human immunodeficiency virus (HIV)-infected patients receiving rifampicin and 70 HIV-infected patients not receiving rifampicin were enrolled to receive 400 mg of nevirapine-based highly active antiretroviral therapy per day. Mean plasma nevirapine levels at 8 and 12 weeks were lower in patients receiving rifampicin (P = .048). However, virological and immunological outcomes at 24 weeks were not different between the 2 groups (P > .05). © 2006 by the Infectious Diseases Society of America. All rights reserved.
ISSN: 10584838
Appears in Collections:Scopus 2006-2010

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.